Since 2015, RYSE Asset Management LLP (RYSE) is a healthcare, technology, and impact investment firm building a global digital future for healthcare.
RYSE ran an investment programme in an exclusive partnership with DigitalHealth.London and MedCity in 2018, 2019, and 2020. We have a unique relationship with the NHS to identify, support, and invest in leading early-stage digital healthcare companies to help them scale globally.
Our investment programme and relationships with incubators, accelerators, co-investors, universities, hospitals, and embassies globally.
Our process is designed around key early stage company milestones and is supported by our advisors.
Our panel of stakeholders assess founder and product market fit to further evaluate company forecasts.
Our network of seasoned investors, mentors, academics, and industry experts help to build and scale our companies.
Our team provides healthcare buyer access, testbed access, and insight into central NHS policy.
Our team and network provide access to alternative global distribution channels and exit strategies (healthcare providers, insurance, technology, pharmaceutical companies).